SOLVENTUM
Live / Applied — First extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 15 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98133250
- Mark type
- Stylized text
- Filed
- 15 Aug 2023
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Michael S. Metteauer
Goods and services
- Class 044 — Medical, beauty and agricultural services: Therapeutic wound care services; Monitoring and remote monitoring of individuals or groups for medical treatment; Medical, orthodontic and dental consultation services; Medical consulting services in the fields of disease infection control, intravenous line care and maintenance, and skin protection; Consulting services provided to medical and healthcare professionals and healthcare facilities regarding best practices in the use, care and maintenance of intravenous lines, reducing infection rates and intravenous line complications, and protecting skin from damage, and regarding the proper usage of medical devices, namely, intravenous lines, medical devices for use in connection therewith, and medical dressings for use at infusion catheter and intravenous sites; Medical consulting services provided to medical and healthcare professionals and healthcare facilities regarding disease infection control and workflow and process improvement for management and improvement of clinical outcomes; Medical consulting services provided to medical and healthcare professionals and healthcare facilities regarding best practices in the use, care and maintenance of medical devices, namely, intravenous lines, medical devices for use in connection therewith, medical dressings for use at infusion catheter and intravenous sites, medical tapes and adhesives used for securing medical tubing and devices, medical tubing and medical apparatus for warming and cooling a patient's body temperature, managing patient hypothermia, warming blood and IV fluids, and monitoring and recording a patient's body temperature; Medical consulting services provided to medical and healthcare professionals and healthcare facilities regarding reducing infection rates and intravenous line complications, protecting skin from damage, and managing wound sites, conditions that impact skin, the care and maintenance of skin, and blood stream infections; Medical consulting services provided to medical and healthcare professionals and healthcare facilities regarding monitoring, and improving best practices in, sterilization procedures used in the medical field; Medical services, namely, providing information related to advanced wound care, negative pressure wound therapy, and therapeutic support systems; Monitoring, tracking, and reporting medical conditions, medical data, and medical records, namely, medical diagnostic testing, monitoring and reporting services in the nature of remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Medical diagnostic monitoring and reporting services, namely, monitoring and reporting the medical condition of individuals; Therapeutic healthcare services, particularly the automated alternating application of negative pressure wound therapy and controlled delivery of topical solutions to a wound site; Tissue therapy and tissue therapy control services, namely, the provision of reduced pressure tissue treatment using therapeutic devices with wound site feedback control systems for optimizing control of the therapy
Owner
- SOLVENTUM INTELLECTUAL PROPERTIES COMPANY, Maplewood, MN, US
- SOLVENTUM INTELLECTUAL PROPERTIES COMPANY, Maplewood, MN, US
- 3M Healthcare Intellectual Properties Company, St Paul, MN, US
Prosecution history
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 1 GRANTED
- 16 Mar 2026 — SOU EXTENSION 1 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Apr 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 22 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 30 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED